COWEN AND COMPANY, LLC 13D/13G Filings for

COWEN AND COMPANY, LLC 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
08:37 am
Unchanged
2024-09-30 13G UroGen Pharma Ltd.
URGN
COWEN AND COMPANY, LLC 1,796,589
4.300%
0
(Unchanged)
Filing
2024-06-24
5:25 pm
Purchase
2024-06-19 13G UroGen Pharma Ltd.
URGN
COWEN AND COMPANY, LLC 1,796,589
4.360%
1,796,589increase
(New Position)
Filing